Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals3 years agoKirkland Advises Butterfly on Closing of $1 Billion Food-Focused FundRead MoreFacebookX.comPinterestLinkedinEmail537100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals3 years agoKirkland Advises Team on $280 Million Sale of its Quest Integrity BusinessRead MoreFacebookX.comPinterestLinkedinEmail526100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals3 years agoKirkland Represents Arsenal Capital Partners on Final Closes of Two New Funds Totaling $5.4 BillionRead MoreFacebookX.comPinterestLinkedinEmail535100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLLegal DesireDeals3 years agoLatham Advises Ontario Teachers’ on Acquisition of Majority Stake in Sahyadri HospitalsRead MoreFacebookX.comPinterestLinkedinEmail532100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLLegal DesireDeals3 years agoLatham Advises J.P. Morgan in Connection with Ukraine’s c. US$20 Billion Debt Restructuring Consent SolicitationsRead MoreFacebookX.comPinterestLinkedinEmail536100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLLegal DesireDeals3 years agoLatham & Watkins Represents AerSale in Secondary Offering of Common StockRead MoreFacebookX.comPinterestLinkedinEmail537100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLLegal DesireDeals3 years agoLatham & Watkins Advises CDPQ on CleverTap’s Series D RoundRead MoreFacebookX.comPinterestLinkedinEmail534100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals3 years agoLatham & Watkins Advises on Sovos Brands’ Secondary Public OfferingRead MoreFacebookX.comPinterestLinkedinEmail532100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals3 years agoLatham & Watkins Advises Boston Scientific Corporation in its Acquisition of Obsidio, Inc.Read MoreFacebookX.comPinterestLinkedinEmail540100
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals3 years agoLatham & Watkins Advises on Halozyme Therapeutics, Inc.’s Upsized Private Offering of $625 Million of Convertible Senior NotesRead MoreFacebookX.comPinterestLinkedinEmail535100
